title: Septicemias in cancer patients during parenteral nutrition: contributing factors and detection by weekly blood cultures.
abstract: Infections constitute the main complication of parenteral nutrition, particularly in cancer patients, but prediction of catheter-related septicemias (CRS) has been little investigated. We have evaluated, in 200 consecutive episodes of parenteral nutrition (PN) in cancer patients, the factors contributing to infectious complications, and the predictive value of weekly blood cultures performed through the nutrition catheter. The median duration of PN was 22 days with a total of 5816 patient-days of PN, neutropenia (neutrophils < 1,000/microl) being present in 872 (15%). Catheters were placed either in a jugular vein (71% single-lumen silicone catheters, 18.5% double-lumen Hickman-Broviac catheters) or in a femoral vein (10.5%). We observed 62 episodes of septicemia of which 22 were CRS (11% incidence for the 200 cycles) and 40 were non-CRS (20% incidence); CRS were mostly due to Staphylococcus epidermidis (14/22). Neutropenic patients as a group did not suffer more CRS than non-neutropenic patients, but the risk of CRS was slightly increased when expressed per day of neutropenia (8 CRS/872 days vs 14 CRS/4942 days without neutropenia, P < 0.05). On the other hand, a femoral insertion site was associated with a much higher incidence of CRS (9 CRS/21 femoral catheters vs 13 CRS/179 jugular catheters, P < 0.0001). It was possible to evaluate 20 episodes of CRS for their predictability by weekly blood cultures: the sensitivity for detecting CRS due to Staphylococcus epidermidis was 67%, the specificity 92%, the negative predictive value 98% and the positive predictive value 36%. The simple and widely available procedure of routine surveillance blood cultures performed through the PN catheter should be further investigated, because it could help the clinician to determine the origin of recent fever, particularly to exclude CRS and avoid unnecessary removal of PN catheters.
authors.affiliation: Services de Médecine et de Chirurgie, Laboratoire d'Investigation Clinique H.J. TAGNON (Unité d'Endocrinologie), Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, 1, rue Héger-Bordet, 1000 Brussels, Belgium.
authors.forename: J J
authors.initials: JJ
authors.lastname: Body
authors.forename: V
authors.initials: V
authors.lastname: Richard
authors.forename: J C
authors.initials: JC
authors.lastname: Pector
authors.forename: A
authors.initials: A
authors.lastname: Lemaire
authors.forename: S
authors.initials: S
authors.lastname: Deshpande
authors.forename: E
authors.initials: E
authors.lastname: Verheye
authors.forename: A
authors.initials: A
authors.lastname: Borkowski
authors.forename: F
authors.initials: F
authors.lastname: Meunier